Clinical Trial Update: Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update on a Dec+Flu+Bu conditioning regimen for elderly AML patients undergoing allogeneic hematopoietic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Allogeneic Hematopoietic Stem Cell Transplantation

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Acute Myeloid Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2, Phase 3 | Status: UNKNOWN